These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 26404408

  • 1. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W, Shi WK, Wang PF, Zeng XT, Li P, Zhang JR, Li Q, Tang ZP, Peng J, Wu LZ, Xie MQ, Liu C, Li XH, Wang YC, Xiao ZP, Zhu HL.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6602-11. PubMed ID: 26404408
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
    Wei W, Liu Q, Li ZZ, Shi WK, Fu X, Liu J, Zhu X, Wang XC, Xu N, Li TF, Jiang FR, Xiao ZP, Zhu HL.
    Eur J Med Chem; 2017 Jun 16; 133():62-68. PubMed ID: 28380394
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP, Wei W, Wang PF, Shi WK, Zhu N, Xie MQ, Sun YW, Li LX, Xie YX, Zhu LS, Tang N, Ouyang H, Li XH, Wang GC, Zhu HL.
    Eur J Med Chem; 2015 Sep 18; 102():631-8. PubMed ID: 26318069
    [Abstract] [Full Text] [Related]

  • 4. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP, Ma TW, Liao ML, Feng YT, Peng XC, Li JL, Li ZP, Wu Y, Luo Q, Deng Y, Liang X, Zhu HL.
    Eur J Med Chem; 2011 Oct 18; 46(10):4904-14. PubMed ID: 21856050
    [Abstract] [Full Text] [Related]

  • 5. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Xiao ZP, Ouyang H, Wang XD, Lv PC, Huang ZJ, Yu SR, Yi TF, Yang YL, Zhu HL.
    Bioorg Med Chem; 2011 Jul 01; 19(13):3884-91. PubMed ID: 21669535
    [Abstract] [Full Text] [Related]

  • 6. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Wang XD, Deng RC, Dong JJ, Peng ZY, Gao XM, Li ST, Lin WQ, Lu CL, Xiao ZP, Zhu HL.
    Bioorg Med Chem; 2013 Sep 01; 21(17):4914-22. PubMed ID: 23891164
    [Abstract] [Full Text] [Related]

  • 7. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW, Wang PF, Tang DJ, Tao XX, Man RJ, Qiu HY, Wang ZC, Xu C, Zhu HL.
    Chem Biol Drug Des; 2016 Oct 01; 88(4):592-8. PubMed ID: 27206529
    [Abstract] [Full Text] [Related]

  • 8. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
    Li QS, Ni HJ, Yang Y, Lv XH, Ruan BF.
    Med Chem; 2015 Oct 01; 11(3):305-13. PubMed ID: 25219926
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM, Gad-Elkareem MAM, Hassane Anouar E, Aouadi K, Kadri A, Snoussi M.
    Bioorg Chem; 2020 Sep 01; 102():104105. PubMed ID: 32717689
    [Abstract] [Full Text] [Related]

  • 10. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D, Pang L, Mattelaer CA, Nautiyal M, De Graef S, Rozenski J, Strelkov SV, Lescrinier E, Weeks SD, Van Aerschot A.
    Bioorg Med Chem; 2020 Aug 01; 28(15):115580. PubMed ID: 32631562
    [Abstract] [Full Text] [Related]

  • 11. Natural Compounds as Inhibitors of Tyrosyl-tRNA Synthetase.
    Skupińska M, Stępniak P, Łętowska I, Rychlewski L, Barciszewska M, Barciszewski J, Giel-Pietraszuk M.
    Microb Drug Resist; 2017 Apr 01; 23(3):308-320. PubMed ID: 27487455
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
    Guo ZH, Yin Y, Wang C, Wang PF, Zhang XT, Wang ZC, Zhu HL.
    Bioorg Med Chem; 2015 Sep 15; 23(18):6148-56. PubMed ID: 26304108
    [Abstract] [Full Text] [Related]

  • 13. Triaminotriazine DNA helicase inhibitors with antibacterial activity.
    McKay GA, Reddy R, Arhin F, Belley A, Lehoux D, Moeck G, Sarmiento I, Parr TR, Gros P, Pelletier J, Far AR.
    Bioorg Med Chem Lett; 2006 Mar 01; 16(5):1286-90. PubMed ID: 16343901
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.
    Xiao ZP, He XB, Peng ZY, Xiong TJ, Peng J, Chen LH, Zhu HL.
    Bioorg Med Chem; 2011 Mar 01; 19(5):1571-9. PubMed ID: 21330140
    [Abstract] [Full Text] [Related]

  • 15. Tyrosyl-tRNA synthetase inhibitors: a patent review.
    Sun J, Lv PC, Zhu HL.
    Expert Opin Ther Pat; 2017 May 01; 27(5):557-564. PubMed ID: 27977303
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F, Wen Q, Wang SF, Shahla Karim B, Yang YS, Liu JJ, Zhang WM, Zhu HL.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):90-5. PubMed ID: 24332628
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF, Yin Y, Qiao F, Wu X, Sha S, Zhang L, Zhu HL.
    Bioorg Med Chem; 2014 Apr 15; 22(8):2409-15. PubMed ID: 24680059
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of carbocyclic analogues of the natural product SB-219383.
    Jarvest RL, Berge JM, Houge-Frydrych CS, Mensah LM, O'Hanlon PJ, Pope AJ.
    Bioorg Med Chem Lett; 2001 Sep 17; 11(18):2499-502. PubMed ID: 11549455
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and activity of analogues of SB-219383: novel potent inhibitors of bacterial tyrosyl tRNA synthetase.
    Berge JM, Broom NJ, Houge-Frydrych CS, Jarvest RL, Mensah L, McNair DJ, O'Hanlon PJ, Pope AJ, Rittenhouse S.
    J Antibiot (Tokyo); 2000 Nov 17; 53(11):1282-92. PubMed ID: 11213289
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M, Anderluh M, Knez D, Randall CP, Barreteau H, O'Neill AJ, Blanot D, Gobec S.
    Eur J Med Chem; 2014 Feb 12; 73():83-96. PubMed ID: 24384549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.